Federal Circuit Refuses Rehearing Of Homocysteine Assay Patent Case

Law360, New York (August 6, 2004, 12:00 AM EDT) -- The U.S. Court of Appeals for the Federal Circuit has denied LabCorp's petition for a rehearing of a lawsuit brought by Competitive Technologies on behalf of two university clients over a homocysteine assay patent.

"CTT and its clients have successfully prevailed in multiple venues in this important case. We applaud the Court of Appeals for the Federal Circuit’s decision to reaffirm the lower court's decision and will work with LabCorp for a final licensing agreement,” John B. Nano, CTT's President and CEO, said in a statement....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.